Defendant Name:
American Renal Associates Holdings, Inc.
Defendant Type:
Public Company
SIC Code:
8092
CUSIP:
02922710
Initial Case Details
Legal Case Name
SEC v. American Renal Associates Holdings, Inc., Jonathan L. Wilcox, Jason M. Boucher, and Karen J. Smith
First Document Date
06-Dec-2021
Initial Filing Format
Civil Proceeding
Case Number
21-cv-10366
Allegation Type
Issuer Reporting and Disclosure
Federal District Court
New York, Southern District of New York
Violations Alleged
•
Sec 17(a) (Not specified)
Additionally,
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 10(b) + Rule 10b-5 of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 10(b) + Rule 10b-5 of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 10(b) + Rule 10b-5 of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 12b-20 of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 12b-20 of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 12b-20 of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(a) of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(a) of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(a) of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-1 of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-1 of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-1 of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-11 of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-11 of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-11 of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-13 of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-13 of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Rule 13a-13 of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(b)(2)(A) of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act (willfully/knowingly).
Jonathan L. Wilcox is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 17(a) (Not specified) of the Securities Act (willfully/knowingly).
Jason M. Boucher is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 17(a) (Not specified) of the Securities Act (willfully/knowingly).
Karen J. Smith is alleged to have aided and abetted American Renal Associates Holdings, Inc.'s violation of Sec 17(a) (Not specified) of the Securities Act (willfully/knowingly).
Resolutions
First Resolution Date
06-Dec-2021
Headline Total Penalty and Disgorgement
See Related Documents
Related Documents:
Complaint
The SEC stated: "This is an accounting fraud case arising from a multimillion dollar scheme by three
former ARA finance executives--Wilcox, Boucher, and Smith--to improperly manipulate
certain revenue adjustments to make it appear that ARA's financial performance was better than
it actually was."
SEC Charges Dialysis Provider and Three Former Senior Executives with Revenue Manipulation Scheme
The SEC stated: "[It] charged American Renal Associates Holdings, Inc. (ARA), a provider of dialysis services through clinics across the country, with engaging in a revenue manipulation scheme that resulted in the restatement of several years of financial reporting. The SEC also charged two of ARA's former chief financial officers, Jonathan Wilcox and Jason Boucher, and former ARA Controller, Karen Smith, for their misconduct related to the scheme."
2021-252
06-Dec-2021
Press Release--Civil Action
SEC Charges Dialysis Provider and Three Former Senior Executives with Revenue Manipulation Scheme
The SEC stated that: "[It] charged American Renal Associates Holdings, Inc. (ARA), a provider of dialysis services through clinics across the country, with engaging in a revenue manipulation scheme that resulted in the restatement of several years of financial reporting. The SEC also charged two of ARA’s former chief financial officers, Jonathan Wilcox and Jason Boucher, and former ARA Controller, Karen Smith, for their misconduct related to the scheme."
Final Judgment as to Defendant American Renal Associates Holdings, Inc.
The Court stated: "Defendant
American Renal Associates Holdings, Inc. (“Defendant”) . . .
consented to the Court’s jurisdiction over Defendant and the subject matter of this action;
consented to entry of this Final Judgment without admitting or denying the allegations of the
Complaint (except as to jurisdiction); waived findings of fact and conclusions of law; and waived
any right to appeal from this Final Judgment."
Other Defendants in Action:
